Fayetteville, Arkansas Clinical Trials

A listing of Fayetteville, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 32 clinical trials
Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over express c-Met (c-Met+) best suited for telisotuzumab vedotin therapy in the second line or third line setting (Stage 1) and then to expand the group(s) to further evaluate efficacy in the selected population(s) (Stage …

cancer chemotherapy
systemic therapy
growth factor
c-MET
cancer treatment
Highlands Oncology Group /ID# 215600
 (6.3 away) Contact site
  • 118 views
  • 03 Aug, 2021
  • +366 other locations
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.

mini-mental state examination
positron emission tomography
flortaucipir
florbetapir
alzheimer's disease
Health Initiatives Research
 (1.2 away) Contact site
  • 80 views
  • 24 Jul, 2021
  • +389 other locations
Pivotal Randomized Open-label Study of Optune (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM

To test the effectiveness and safety of Optune given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM patients, compared to radiation therapy and temozolomide alone. In both arms, Optune and maintenance temozolomide are continued following radiation therapy.

MRI
complete resection
tumor progression
gross total resection
karnofsky performance status
Highland Oncology Group
 (1.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +157 other locations
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age

This study is designed to evaluate the safety and immunogenicity of 20vPnC in healthy children 15 months through 17 years of age

pneumococcal conjugate
conjugate vaccine
Northwest Arkansas Pediatrics
 (1.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +46 other locations
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

This is an event driven, adaptive design, a randomized, active-controlled, multicenter, open-label, parallel groups, Phase 3 study of DSP-7888 Dosing Emulsion plus Bevacizumab versus Bevacizumab alone in patients with recurrent or progressive glioblastoma multiforme (GBM) following treatment with first line therapy consisting of surgery and radiation with or without chemotherapy.

tumor treating fields therapy
aptt
bevacizumab
methylated
chemoradiotherapy
Highlands Oncology Group
 (1.2 away) Contact site
  • 1520 views
  • 31 Jul, 2021
  • +72 other locations
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer …

nicotine lozenge
motivational interviewing
cigarette smoke
tobacco smoke
cancer
Highlands Oncology Group
 (7.8 away) Contact site
  • 687 views
  • 31 Jul, 2021
  • +18 other locations
A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Late Preterm and Term Infants

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics (PK), and antidrug antibody (ADA) response for MEDI8897 in healthy late preterm and term infants who are 35 weeks or greater gestational age and entering their first RSV season.

Research Site
 (1.2 away) Contact site
  • 574 views
  • 28 Jul, 2021
  • +404 other locations
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Receptor (FGFR) Gene Alterations

The purpose of this study is to evaluate the efficacy of erdafitinib in terms of overall response rate (ORR) in participants with advanced solid tumors with fibroblast growth factor receptor (FGFR) mutations and gene fusions.

cancer
growth factor
solid tumour
measurable disease
Highlands Oncology Group
 (1.2 away) Contact site
  • 39 views
  • 26 Jul, 2021
  • +265 other locations
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease.

The study is intended to show superiority of AZD9833 in combination with palbociclib (a CDK4/6 inhibitor) versus anastrozole (an aromatase inhibitor) and palbociclib as the initial treatment of patients with hormone receptor-positive (ER-positive), human epidermal growth factor 2-negative (HER2-negative) advanced/metastatic breast cancer.

Research Site
 (6.3 away) Contact site
  • 0 views
  • 02 Aug, 2021
  • +195 other locations
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter …

metastatic urothelial carcinoma
intravesical chemotherapy
immune checkpoint inhibitor
bladder cancer
radical cystectomy
Highlands Oncology Group
 (1.2 away) Contact site
  • 284 views
  • 23 Jul, 2021
  • +92 other locations